Cite
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer.
MLA
Boisen, Michelle M., et al. “Second-Line Intraperitoneal Platinum-Based Therapy Leads to an Increase in Second-Line Progression-Free Survival for Epithelial Ovarian Cancer.” International Journal of Gynecological Cancer, vol. 26, no. 4, May 2016, pp. 626–31. EBSCOhost, https://doi.org/10.1097/IGC.0000000000000667.
APA
Boisen, M. M., Lesnock, J. L., Richard, S. D., Beriwal, S., Kelley, J. L., Zorn, K. K., & Edwards, R. P. (2016). Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer. International Journal of Gynecological Cancer, 26(4), 626–631. https://doi.org/10.1097/IGC.0000000000000667
Chicago
Boisen, Michelle M., Jamie L. Lesnock, Scott D. Richard, Sushil Beriwal, Joseph L. Kelley, Kristin K. Zorn, and Robert P. Edwards. 2016. “Second-Line Intraperitoneal Platinum-Based Therapy Leads to an Increase in Second-Line Progression-Free Survival for Epithelial Ovarian Cancer.” International Journal of Gynecological Cancer 26 (4): 626–31. doi:10.1097/IGC.0000000000000667.